Hebert, Adelaide, Rhonda Schrieber, Debbie Glaab, and Lawrence Eichenfield. 2020. “Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol Propionate Foam, 0.05% in Adolescent Subjects With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 4 (6):s77. https://doi.org/10.25251/skin.4.supp.77.